Wildfire-specific fine particulate matter and preterm birth: a US ECHO Cohort analysis
- PMID: 41197644
- PMCID: PMC12885132
- DOI: 10.1016/j.lanplh.2025.101324
Wildfire-specific fine particulate matter and preterm birth: a US ECHO Cohort analysis
Abstract
Background: Exposure to PM2·5 from wildfire smoke during pregnancy has been implicated as a risk factor for preterm birth. We investigated this association in the prospective nationwide US Environmental Influences on Child Health Outcomes (ECHO) Cohort, focusing on prenatal wildfire PM2·5 exposure intensity, duration, and timing.
Methods: In this cohort analysis, we included live singleton births recorded in the ECHO Cohort with available data on gestational age at birth and birthweight and dates of conception between Jan 1, 2006, and March 20, 2020. Census tract-level estimates of daily mean wildfire-derived PM2·5 for the years 2006-20 from a previous machine learning model were linked to residential address history. We calculated the mean concentration of daily wildfire PM2·5, days with wildfire PM2·5 (>0, ≥2·5, ≥5·0, and ≥10·0 μg/m3; termed smoke days) and consecutive smoke days (2, 3, or ≥4 days; termed smoke waves) above the prespecified concentration thresholds across pregnancy. Associations of cumlative pregnancy wildfire PM2·5 exposure with preterm birth (delivery before 37 weeks of gestation) were analysed by adjusted pooled logistic regression in the nationwide ECHO sample and in the US West census region. Associations between smoke days in gestational weeks 0-35 and preterm birth were evaluated by logistic regression in the national sample.
Findings: We included 20 034 births from 30 ECHO Cohort study sites, with residences during pregnancy in all 48 contiguous US states and the District of Columbia. 1687 (8·4%) of the 20 034 infants were preterm. The mean daily wildfire PM2·5 concentration during pregnancy was 0·36 μg/m3 (SD 0·46), with exposure to a mean of 22·2 smoke days (SD 16·6) of any wildfire PM2·5 concentration (>0 μg/m3). Estimates of association between wildfire PM2·5 exposure metrics and preterm birth included the null in nationwide analyses; whereas, in the US West sample (N=5807), we estimated increased odds of preterm birth associated with mean daily wildfire PM2·5 (odds ratio [OR] 1·139 per 1-μg/m3 increase [95% CI 1·001-1·296]), exposure to smoke days with a wildfire PM2·5 concentration of 5·0 μg/m3 or greater (OR 1·018 per additional smoke day [1·003-1·032]) and 10·0 μg/m3 or greater (OR 1·030 [1·006-1·054]), and exposure to ≥4-day smoke waves of 5·0 μg/m3 or greater (OR 1·185 per additional smoke wave [1·044-1·347]) and 10·0 μg/m3 or greater (OR 1·232 [1·029-1·475]). At the national level, by week of gestation, associations with preterm birth were observed in mid-pregnancy for smoke days with wildfire PM2·5 concentrations above 0 μg/m3, of 2·5 μg/m3 or greater, and of 5·0 μg/m3 or greater, and in late pregnancy for smoke days of 10·0 μg/m3 or greater.
Interpretation: In a prospective cohort, we observed increased odds of preterm birth associated with wildfire PM2·5 exposure in the western USA, with findings suggesting an exposure-response relationship for increasing exposure intensity and duration. Preterm birth was also associated with exposure to smoke days in mid-to-late pregnancy at the national level. For practice and policy, these findings support the need for public health interventions aimed at reducing exposure to wildfire smoke during pregnancy.
Funding: ECHO Program, US National Institutes of Health Office of the Director.
Copyright © 2025 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests AEH was a member of a data safety and monitoring board for a treatment trial of blood pressure management at the University of Pittsburgh. ARS consulted for UNICEF on an analysis of child exposure to pesticides. CJK received an honorarium from Kaiser Permanente to present for paediatricians on wildfire smoke and child health, and received an honorarium and travel support from California Chapter 2 of the American Academy of Pediatrics to present on provider medical education related to air pollution and child health. CTM was chair of a data safety and monitoring board for a US National Institutes of Health (NIH) study, Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia (SILDI-SAFE), and member of a data safety and monitoring board for the Pragmatic Research on Diuretic Management in Early BPD (PRIMED) Study. CTM also received annual fees and royalties as a peer reviewer for UpToDate, and honoraria for lectures including at an Endowed Lectureship at the University of Illinois in March, 2024, the Vermont Oxford Hot Topics Meeting in December, 2024, and the Mednax Center for Research, Education, Quality and Safety Annual Conference for Neonatology in February, 2025. DH was a member of an advisory committee for the Targeting Environmental Neurodevelopmental Risks Project. JA served on the Avera Health Institutional Review Board. RJS has received funding support from the Bia-Echo Foundation. RJS also consults for Linus Technology, and consulted for the Beasley Law Firm until March, 2023. RJS also received travel support to serve on the Observational Study Monitoring Board for the Healthy Brain and Child Development (HBCD) Study, to present at the BC Lung Foundation Air Quality & Health Workshop 2025 (April, 2025), to present at the Japan Society of Endocrine Disruptors Research Meeting (December, 2024), to present at the Society for Birth Defects Research and Prevention 64th Annual Meeting (June, 2024), and to present at the 35th Annual Meeting of the Organization of Teratology Information Specialists (June, 2023). All other authors declare no competing interests.
Figures
References
-
- Padula AM, Raynes-Greenow C. Health effects of wildfire smoke during pregnancy and childhood. In: Loboda TV, French NHF, Puett RC, eds. Landscape fire, smoke, and health. American Geophysical Union, 2024: 249–63.
-
- Frey HA, Klebanoff MA. The epidemiology, etiology, and costs of preterm birth. Semin Fetal Neonatal Med 2016; 21: 68–73. - PubMed
MeSH terms
Substances
Grants and funding
- UG3 OD035528/OD/NIH HHS/United States
- UG3 OD035517/OD/NIH HHS/United States
- UG3 OD035540/OD/NIH HHS/United States
- UH3 OD023286/OD/NIH HHS/United States
- UG3 OD035532/OD/NIH HHS/United States
- UG3 OD035519/OD/NIH HHS/United States
- U24 OD035523/OD/NIH HHS/United States
- UH3 OD023287/OD/NIH HHS/United States
- P30 ES007033/ES/NIEHS NIH HHS/United States
- UG3 OD035533/OD/NIH HHS/United States
- UG3 OD035518/OD/NIH HHS/United States
- UG3 OD035529/OD/NIH HHS/United States
- UH3 OD023320/OD/NIH HHS/United States
- UH3 OD023268/OD/NIH HHS/United States
- U2C ES026533/ES/NIEHS NIH HHS/United States
- U24 OD023382/OD/NIH HHS/United States
- UH3 OD023332/OD/NIH HHS/United States
- U2C ES026542/ES/NIEHS NIH HHS/United States
- UG3 OD035509/OD/NIH HHS/United States
- U2C ES026555/ES/NIEHS NIH HHS/United States
- U2C ES030857/ES/NIEHS NIH HHS/United States
- U2C ES026561/ES/NIEHS NIH HHS/United States
- U2C OD023375/OD/NIH HHS/United States
- UG3 OD035544/OD/NIH HHS/United States
- U24 ES026539/ES/NIEHS NIH HHS/United States
- UH3 OD023318/OD/NIH HHS/United States
- UG3 OD035521/OD/NIH HHS/United States
- UH3 OD023271/OD/NIH HHS/United States
- UG3 OD035508/OD/NIH HHS/United States
- UG3 OD035546/OD/NIH HHS/United States
- U24 OD023319/OD/NIH HHS/United States
- UG3 OD035543/OD/NIH HHS/United States
- U2C ES030851/ES/NIEHS NIH HHS/United States
- U2C ES030859/ES/NIEHS NIH HHS/United States
- UG3 OD035550/OD/NIH HHS/United States
- UG3 OD035537/OD/NIH HHS/United States
- UH3 OD023347/OD/NIH HHS/United States
- UG3 OD035542/OD/NIH HHS/United States
- UG3 OD035526/OD/NIH HHS/United States
- UG3 OD035527/OD/NIH HHS/United States
- UG3 OD035536/OD/NIH HHS/United States
- UG3 OD035513/OD/NIH HHS/United States
- UG3 OD035516/OD/NIH HHS/United States
- UH3 OD023328/OD/NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
